A. D. Beadell Investment Counsel, Inc. Abbott Laboratories Transaction History

A. D. Beadell Investment Counsel, Inc.

$125 Million
Q3 2024

A detailed history of A. D. Beadell Investment Counsel, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, A. D. Beadell Investment Counsel, Inc. holds 25,550 shares of ABT stock, worth $3.01 Million. This represents 2.33% of its overall portfolio holdings.

Number of Shares

25,550

Previous 25,550 -0.0%

Holding current value

$3.01 Million

Previous $2.65 Million 9.72%

% of portfolio

2.33%

Previous 2.22%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 12, 2024	SELL	$100.73 - $112.44 $120,876 - $134,928	-1,200 Reduced 4.49%	25,550 $2.65 Million
Q1 2024 Apr 12, 2024	SELL	$109.52 - $120.96 $393,724 - $434,851	-3,595 Reduced 11.85%	26,750 $3.04 Million
Q4 2023 Jan 18, 2024	SELL	$90.19 - $110.4 $44,193 - $54,096	-490 Reduced 1.59%	30,345 $3.34 Million
Q3 2023 Oct 13, 2023	BUY	$95.53 - $114.62 $14,329 - $17,193	150 Added 0.49%	30,835 $2.99 Million
Q2 2023 Jul 13, 2023	SELL	$100.78 - $112.29 $534,134 - $595,137	-5,300 Reduced 14.73%	30,685 $3.35 Million
Q1 2023 Apr 12, 2023	SELL	$96.86 - $114.01 $119,137 - $140,232	-1,230 Reduced 3.31%	35,985 $3.64 Million
Q3 2022 Oct 13, 2022	BUY	$96.76 - $112.03 $43,542 - $50,413	450 Added 1.22%	37,215 $3.6 Million
Q2 2022 Jul 15, 2022	SELL	$102.07 - $123.37 $81,656 - $98,696	-800 Reduced 2.13%	36,765 $3.99 Million
Q1 2022 Apr 12, 2022	SELL	$114.02 - $139.04 $57,010 - $69,520	-500 Reduced 1.31%	37,565 $4.45 Million
Q4 2021 Jan 19, 2022	SELL	$115.53 - $141.46 $198,711 - $243,311	-1,720 Reduced 4.32%	38,065 $5.36 Million
Q2 2021 Jul 29, 2021	SELL	$105.79 - $124.53 $44,960 - $52,925	-425 Reduced 1.06%	39,785 $4.61 Million
Q1 2021 Apr 15, 2021	SELL	$108.84 - $128.23 $76,188 - $89,761	-700 Reduced 1.71%	40,210 $4.82 Million
Q4 2020 Jan 15, 2021	SELL	$105.0 - $114.42 $15,750 - $17,163	-150 Reduced 0.37%	40,910 $4.48 Million
Q3 2020 Nov 02, 2020	SELL	$91.64 - $111.29 $5,040 - $6,120	-55 Reduced 0.13%	41,060 $4.47 Million
Q2 2020 Jul 15, 2020	SELL	$76.57 - $98.0 $46,707 - $59,780	-610 Reduced 1.46%	41,115 $3.76 Million
Q3 2019 Oct 24, 2019	SELL	$81.84 - $88.74 $36,828 - $39,933	-450 Reduced 1.07%	41,725 $3.49 Million
Q2 2019 Jul 17, 2019	SELL	$72.88 - $85.0 $7,288 - $8,500	-100 Reduced 0.24%	42,175 $3.55 Million
Q1 2019 Apr 24, 2019	SELL	$66.22 - $80.06 $993 - $1,200	-15 Reduced 0.04%	42,275 $3.38 Million
Q4 2018 Feb 05, 2019	SELL	$65.56 - $74.27 $303,280 - $343,573	-4,626 Reduced 9.86%	42,290 $3.06 Million
Q3 2018 Oct 23, 2018	SELL	$60.81 - $73.36 $252,361 - $304,444	-4,150 Reduced 8.13%	46,916 $3.44 Million
Q1 2018 Apr 25, 2018	BUY	$56.27 - $63.62 $56 - $63	1 Added 0.0%	51,066 $3.06 Million
Q4 2017 Feb 06, 2018	BUY	$53.68 - $57.47 $53,680 - $57,470	1,000 Added 2.0%	51,065 $2.91 Million
Q3 2017 Oct 25, 2017	BUY	$48.06 - $53.64 $2.41 Million - $2.69 Million	50,065	50,065 $2.67 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of A. D. Beadell Investment Counsel, Inc., based on Form 13F filings with the SEC.

News

Stay updated on A. D. Beadell Investment Counsel, Inc. with notifications on news.

Account

A. D. Beadell Investment Counsel, Inc. Abbott Laboratories Transaction History